Abeona Therapeutics Inc.
ABEO
$5.34
-$0.06-1.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -120.17% | 82.95% | 1,369.52% | 61.91% | 43.99% |
| Total Depreciation and Amortization | 40.72% | 22.99% | 12.12% | 12.57% | 7.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.74% | -99.37% | -520.24% | -119.68% | -174.84% |
| Change in Net Operating Assets | 84.54% | -9,464.61% | 539.42% | -21.48% | -477.93% |
| Cash from Operations | -8.42% | -73.18% | -48.09% | -26.58% | -79.31% |
| Capital Expenditure | -90.26% | -523.76% | -308.02% | -93.24% | -1,537.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.04% | -977.69% | 465.54% | 179.16% | 68.69% |
| Cash from Investing | -49.39% | -947.95% | 453.23% | 153.90% | 63.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -34.45% | -- | -85.75% | 5.95% | -29.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 57.14% | 96.83% | 37.62% |
| Cash from Financing | -31.99% | 1,826.76% | -85.76% | -73.40% | -28.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.70% | -331.29% | 775.02% | -340.55% | -21.82% |